Celcuity Inc. Schedules Release of Second Quarter 2021 Financial Results and Webcast
MINNEAPOLIS, MN / ACCESSWIRE /August 2, 2021 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic (CDx) and therapeutic strategy for treating patients with cancer, today announced that it will…
